quiet_lurker
TL2 Regular · Riga, LV
Two thousand posts read for every one written.
Joined 29 November 2024 · last posted 3d
64 posts, newest first. Showing up to 150.
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #30 · Sourcing › Vendor reports · 25 Jul 2026 · 20 likes Coming back to post #28, because the follow-up matters more than the original answer. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #23 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 5 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
What a regulator's shortage notice actually authorises Replied, post #4 · Sourcing › Regulatory · 4 Jul 2026 · 3 likes I read the opening post twice before replying, because I had assumed the opposite. Import restrictions vary by compound and by jurisdiction: what is a controlled…
-
Pancreatitis history and the risk calculus Replied, post #25 · Safety › Contraindications · 4 Jul 2026 · 1 like This follows post #22 rather than contradicting it. Severe renal impairment (eGFR
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #53 · Sourcing › Independent verification · 30 Jun 2026 · 0 likes I read post #51 twice before replying, because I had assumed the opposite. When results are inconclusive: if a testing service reports "insufficient to verify" on a…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #77 · Compounds › Semaglutide · 24 Jun 2026 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #30 · Compounds › Retatrutide · 5 Jun 2026 · 3 likes Worth separating two things that post #26 runs together. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #27 · Analytics › Method validation · 20 May 2026 · 0 likes Picking up post #24: that is the part I would want checked first. Specificity: the method can distinguish the intended compound from related impurities and degradation…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #15 · Analytics › Home & field testing · 9 May 2026 · 15 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #20 · Compounds › Tirzepatide · 4 May 2026 · 13 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #54 · Evidence › Journal club · 3 May 2026 · 10 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #31 · Evidence › Preprints · 15 Apr 2026 · 9 likes Worth separating two things that post #27 runs together. Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That…
-
Follow-up: State-level differences that actually matter Replied, post #10 · Regional › North America · 4 Apr 2026 · 12 likes Picking up post #7: that is the part I would want checked first. Indigenous healthcare systems: different indigenous healthcare systems have different medication…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #85 · Regional › UK & Ireland · 21 Mar 2026 · 3 likes This follows post #82 rather than contradicting it. Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That…
-
Adolescents: a distinct evidence base — one year on Replied, post #77 · Clinical › Special populations · 21 Mar 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #28 · Start Here › Welcome · 20 Mar 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Interim analyses and stopping rules Replied, post #15 · Evidence › Trials · 6 Mar 2026 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #116 · Access › International · 18 Feb 2026 · 0 likes I read post #114 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #6 · Clinical › Comorbidities · 16 Feb 2026 · 5 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
A payment that went through twice: how it was resolved Replied, post #17 · Sourcing › Payments · 10 Feb 2026 · 1 like Picking up post #14: that is the part I would want checked first. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #21 · Research Methods › Statistics · 29 Jan 2026 · 1 like Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
A history of disordered eating: proceeding carefully Replied, post #56 · Wellbeing › Mental health · 10 Jan 2026 · 25 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
Dead volume across syringe and needle combinations Replied, post #46 · Devices › Syringes & needles · 29 Dec 2025 · 0 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #23 · Clinical › Bloodwork · 15 Dec 2025 · 0 likes Worth separating two things that post #19 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Specification in the result column: why that is a meaningful error Replied, post #86 · Analytics › COA interpretation · 9 Dec 2025 · 16 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #60 · Wellbeing › Mental health · 8 Dec 2025 · 0 likes On post #56 — agreed on the reasoning, with one qualification. Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift…
-
Request: a diff view for wiki revisions — the long version Replied, post #74 · Meta › Feature requests · 24 Nov 2025 · 29 likes This follows post #71 rather than contradicting it. Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #64 · Compounds › Tirzepatide · 14 Nov 2025 · 10 likes Picking up post #61: that is the part I would want checked first. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound…
-
[2026 update] What steady state means for the decision to escalate Replied, post #60 · Practice › Dosing & titration · 11 Nov 2025 · 3 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #80 · Sourcing › Vendor reports · 26 Oct 2025 · 17 likes Picking up post #77: that is the part I would want checked first. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
-
Documentation that materially improves an appeal's chances Replied, post #34 · Access › Insurance & coverage · 20 Oct 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #108 · Data & Tools › Calculators · 7 Sep 2025 · 21 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
What this community means by "a source", in practical terms Replied, post #98 · Start Here › Welcome · 3 Sep 2025 · 2 likes This follows post #95 rather than contradicting it. Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #26 · Practice › Side effects · 30 Aug 2025 · 0 likes Picking up post #23: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Trial registration and comparing the protocol with the paper Replied, post #33 · Evidence › Trials · 27 Aug 2025 · 31 likes This follows post #30 rather than contradicting it. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #112 · Wellbeing › Mental health · 16 Aug 2025 · 13 likes On post #108 — agreed on the reasoning, with one qualification. When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with…
-
A ten-fold dose error caught before injection — one year on Replied, post #36 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #63 · Data & Tools › Calculators · 26 Jul 2025 · 27 likes On post #59 — agreed on the reasoning, with one qualification. Titration planning: a calculator that shows you the escalation schedule for different starting and ending…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #6 · Sourcing › Regulatory · 25 Jul 2025 · 15 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
A field-by-field walk through a certificate of analysis Replied, post #95 · Analytics › COA interpretation · 17 Jul 2025 · 18 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #18 · Data & Tools › Datasets · 29 Jun 2025 · 0 likes Picking up post #15: that is the part I would want checked first. Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 11 Jun 2025 · 0 likes Picking up post #18: that is the part I would want checked first. Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses.…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #65 · Compounds › Retatrutide · 10 Jun 2025 · 22 likes I read post #63 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Sodium, potassium and magnesium when intake drops Replied, post #6 · Nutrition & Training › Hydration & electrolytes · 5 Jun 2025 · 3 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Ipamorelin selectivity claims and where they came from Replied, post #40 · Compounds › Secretagogues & GH axis · 23 May 2025 · 11 likes Worth separating two things that post #36 runs together. IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #64 · Practice › Interactions · 28 Apr 2025 · 10 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Coming back to: A critique that turned out to be unfair, retracted by its author Replied, post #2 · Evidence › Study critique · 23 Apr 2025 · 8 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
Reading a supplier's product description as a marketing document Replied, post #13 · Compounds › Other compounds · 15 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #108 · Analytics › COA interpretation · 21 Mar 2025 · 30 likes post #107 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #44 · Pharmacology › Receptor biology · 5 Mar 2025 · 1 like Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #10 · Clinical › Bloodwork · 4 Mar 2025 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Consistent declarations and why they matter more than clever ones Replied, post #57 · Sourcing › Logistics · 20 Feb 2025 · 24 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #49 · Practice › Interactions · 15 Jan 2025 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #19 · Compounds › Tirzepatide · 11 Jan 2025 · 0 likes Picking up post #16: that is the part I would want checked first. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound…
-
Follow-up: Individual participant data versus aggregate data Replied, post #46 · Evidence › Meta-analyses · 9 Jan 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #80 · Clinical › Comorbidities · 22 Oct 2024 · 19 likes post #79 answers the question as asked. The question underneath it is different. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular…
-
Reading a supplementary appendix and finding the interesting part Replied, post #9 · Evidence › Trials · 20 Oct 2024 · 14 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #117 · Clinical › Bloodwork · 17 Oct 2024 · 12 likes I read post #115 twice before replying, because I had assumed the opposite. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual…
-
Request: a diff view for wiki revisions Replied, post #11 · Meta › Feature requests · 15 Sep 2024 · 23 likes Picking up post #8: that is the part I would want checked first. Effort estimation: some features are trivial to implement; others are substantial work. Staff will…
-
Chronic kidney disease and the FLOW result Replied, post #23 · Clinical › Comorbidities · 17 Aug 2024 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #73 · Analytics › COA interpretation · 14 Aug 2024 · 18 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #3 · Evidence › Journal club · 23 Jul 2024 · 12 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #143 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes I read post #141 twice before replying, because I had assumed the opposite. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Cold packs, phase-change material, and what survives ten days Replied, post #32 · Sourcing › Logistics · 21 Jun 2024 · 30 likes Worth separating two things that post #28 runs together. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain…